Agustín Ibáñez

Oct 8, 2024 | nature.com | Agustín Ibáñez |Randall J. Bateman

A trailblazing Latin American leader in Alzheimer’s disease research and a compassionate patient advocate Francisco Lopera, a groundbreaking neurologist who undertook pioneering work in early-onset Alzheimer’s disease (EOAD), passed away on 10 September 2024. He revolutionized the field of Alzheimer’s disease research and was the recipient of several recognitions, including the Potamkin Prize and the Bengt Winblad Lifetime Achievement Award.

Jul 12, 2024 | nature.com | Agustín Ibáñez

Current dementia research has developed complex models of environmental–genetic interactions to better address multimodal disease phenotypes. New evidence highlights a stronger effect of social determinants of health than ancestry effects specific to Latin America and the Caribbean, which opens new agendas to address the diversity of these interactions in ageing and dementia.

May 8, 2024 | cell.com | Agustín Ibáñez |Universidad Adolfo Ibáñez |Santiago de Chile

Brain Capital Alliance, San Francisco, CA, USA Euro-Mediterranean Economists Association, Barcelona, Spain Center for Health and Biosciences, The Baker Institute for Public Policy, Rice University, Houston, TX, USA Meadows Mental Health Policy Institute, Dallas, TX, USA Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University and Barwon Health, Geelong, VIC, Australia Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston,...

Jan 20, 2024 | cell.com | Agustín Ibáñez |Universidad Adolfo Ibáñez

Highlights Cognitive neuroscience of diseases faces challenges dealing with complex structure–function associations, disease phenotype heterogeneity, lack of transdiagnostic models, and oversimplified cognitive approaches. Synergetics offers a unified framework to progressively tackle these challenges, emphasizing the complex dynamics of brain, body, and environmental interactions.

Aug 23, 2023 | frontiersin.org | Agustín Ibáñez

1. Introduction Alzheimer's disease (AD) is the most common cause of dementia and the fifth leading cause of death in adults older than 65. Aged individuals are disproportionately likely to suffer from anxiety, and this higher tendency is related to increased cognitive decline. In fact, aging is a prominent risk factor for AD and many of its comorbidities. AD is a progressive brain disorder that leads to neurodegeneration, cognitive deficits, and memory decline.